KAM
SCLN

Kassirer Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Kassirer Asset Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-15,000
Closed -$168K – 86
2017
Q3 		$168K Hold
15,000
– – 0.16% 65
2017
Q2 		$165K Buy
+15,000
New +$150K 0.12% 77

Kassirer Asset Management's SCLN Position: Q4 2017 in Review

Kassirer Asset Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 15,000 shares — an estimated $168K sold.

Kassirer Asset Management first reported a position in SCLN in Q2 2017 and held it in 2 quarters. The position peaked at $168K in Q3 2017. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.

  • Kassirer Asset Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Kassirer Asset Management sold 15,000 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $168K.
  • Kassirer Asset Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2017 and held it in 2 quarters.
  • Kassirer Asset Management's Sciclone Pharmaceuticals Inc position peaked at $168K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.

Based on Kassirer Asset Management's 13F filing for Q4 2017, filed 5 Feb 2018.